EKF Diagnostics Investor Announcements

EKF Diagnostics, the global in-vitro diagnostics company, announces that Separation Technology, Inc., a subsidiary of EKF, has moved its manufacturing and operations from Sanford, Florida to Boerne, Texas.

EKF Diagnostics, the global in-vitro diagnostics company, announces the release of a significant critical evaluation of the Quo-Test analyzer carried out by the European Reference Laboratory for Gylcohemoglobin. 

EKF Diagnostics, the global in vitro diagnostics company, is looking forward to an exciting second half of 2016 as it relaunches the HemoPoint® H2 hemoglobin analyzer in the USA under the Stanbio brand.